Roche Diagnostics GmbH (manufacturing of unpackaged products, primary packaging, secondary packaging, quality control testing (except biological analysis method "In vivo activity, in normocytemic mice" for stability studies), batch release)
UkraineAll drugs from this manufacturer
-
It is used to treat symptomatic anemia caused by chronic kidney disease in adults and children aged 3 months to 18 years.
Dosage form: solution for injection
Active substance Dosage methoxy polyethylene glycol-epoetin beta 75 mcg 0.3 ml ATC: B03XA03
-
The drug is intended for the treatment of symptomatic anemia associated with chronic kidney disease in adults and children aged 3 months to 18 years.
Dosage form: solution for injection
Active substance Dosage methoxy polyethylene glycol-epoetin beta 50 mcg/0.3 ml ATC: B03XA03